Ho, Jennifer E.

Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association

Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation

Cardiovascular Health and Risk FactorsHealthcare Systems and Public Health

Cited by 8,300

Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association

Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation

Cardiovascular Health and Risk FactorsHealthcare Systems and Public Health

Cited by 5,987

Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association

Ndumele, C. E., Rangaswami, J., Chow, S. L., Neeland, I. J., Tuttle, K. R., Khan, S. S., Coresh, J., Mathew, R. O., Baker-Smith, C. M., Carnethon, M. R., et al. (2023) · Circulation

Diabetes, Cardiovascular Risks, and LipoproteinsChronic Kidney Disease and Diabetes

Cited by 2,208

A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association

Ndumele, C. E., Neeland, I. J., Tuttle, K. R., Chow, S. L., Mathew, R. O., Khan, S. S., Coresh, J., Baker-Smith, C. M., Carnethon, M. R., Després, J.-P., et al. (2023) · Circulation

Diabetes, Cardiovascular Risks, and LipoproteinsChronic Kidney Disease and Diabetes

Cited by 1,405

Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association

Khan, S. S., Coresh, J., Pencina, M. J., Ndumele, C. E., Rangaswami, J., Chow, S. L., Palaniappan, L. P., Sperling, L. S., Virani, S. S., Ho, J. E., et al. (2023) · Circulation

Health Promotion and Cardiovascular PreventionDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 797

Heart Failure With Preserved Ejection Fraction

Borlaug, B. A., Sharma, K., Shah, S. J., & Ho, J. E. (2023) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 742

The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF

Savji, N., Meijers, W. C., Bartz, T. M., Bhambhani, V., Cushman, M., Nayor, M., Kizer, J. R., Sarma, A., Blaha, M. J., Gansevoort, R. T., et al. (2018) · JACC: Heart Failure

Cardiovascular Function and Risk FactorsHeart Failure Treatment and Management

Cited by 499

Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study

Wang, T. J., Wollert, K. C., Larson, M. G., Coglianese, E., McCabe, E. L., Cheng, S., Ho, J. E., Fradley, M. G., Ghorbani, A., Xanthakis, V., et al. (2012) · Circulation

GDF15 and Related BiomarkersHeart Failure Treatment and Management

Cited by 482

Genome‐wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease

Yao, C., Chen, G., Song, C., Keefe, J., Mendelson, M., Huan, T., Sun, B. B., Laser, A., Maranville, J. C., Wu, H., et al. (2018) · Nature Communications

Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals

Cited by 431

Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin

Waters, D. D., Ho, J. E., DeMicco, D. A., Breazna, A., Arsenault, B. J., Wun, C.-C., Kastelein, J. J., Colhoun, H., & Barter, P. (2011) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 333

Deep learning enables genetic analysis of the human thoracic aorta

Pirruccello, J. P., Chaffin, M. D., Chou, E. L., Fleming, S. J., Lin, H., Nekoui, M., Khurshid, S., Friedman, S. F., Bick, A. G., Arduini, A., et al. (2022) · Nature Genetics

Genetic Associations and EpidemiologyAortic Disease and Treatment Approaches

Cited by 210

Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy

Waters, D. D., Ho, J. E., Boekholdt, S. M., DeMicco, D. A., Kastelein, J. J. P., Messig, M., Breazna, A., & Pedersen, T. R. (2013) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 178

Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: Insights from the MGH COVID-19 patient registry

Lau, E. S., McNeill, J. N., Paniagua, S. M., Liu, E. E., Wang, J. K., Bassett, I. V., Selvaggi, C. A., Lubitz, S. A., Foulkes, A. S., & Ho, J. E. (2021) · PLOS ONE

COVID-19 Clinical Research StudiesSepsis Diagnosis and Treatment

Cited by 65

Semaglutide Eligibility Across All Current Indications for US Adults

Shi, I., Khan, S. S., Yeh, R. W., Ho, J. E., Dahabreh, I. J., & Kazi, D. S. (2025) · JAMA Cardiology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 53

Uncovering Unrecognized Heart Failure With Preserved Ejection Fraction Among Individuals With Obesity and Dyspnea

Kosyakovsky, L. B., Liu, E. E., Wang, J. K., Myers, L., Parekh, J. K., Knauss, H., Lewis, G. D., Malhotra, R., Nayor, M., Robbins, J. M., et al. (2024) · Circulation: Heart Failure

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 43

Effect of Phosphodiesterase Inhibition on Insulin Resistance in Obese Individuals

Ho, J. E., Arora, P., Walford, G. A., Ghorbani, A., Guanaga, D. P., Dhakal, B. P., Nathan, D. I., Buys, E. S., Florez, J. C., Newton‐Cheh, C., et al. (2014) · Journal of the American Heart Association

Phosphodiesterase function and regulationDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 39

Natural Language Processing for Adjudication of Heart Failure in a Multicenter Clinical Trial: A Secondary Analysis of a Randomized Clinical Trial

Cunningham, J. W., Singh, P., Reeder, C., Claggett, B., Marti-Castellote, P. M., Lau, E. S., Khurshid, S., Batra, P., Lubitz, S. A., Maddah, M., et al. (2024) · JAMA Cardiology

Artificial Intelligence in HealthcareHeart Failure Treatment and Management

Cited by 38

Natural language processing for adjudication of heart failure in the electronic health record

Cunningham, J. W., Singh, P., Reeder, C., Lau, E. S., Khurshid, S., Wang, X., Ellinor, P. T., Lubitz, S. A., Batra, P., & Ho, J. E. (2023) · JACC: Heart Failure

Machine Learning in HealthcareHeart Failure Treatment and Management

Cited by 21

Natural language processing to adjudicate heart failure hospitalizations in global clinical trials

Marti-Castellote, P. M., Reeder, C., Claggett, B., Singh, P., Lau, E. S., Khurshid, S., Batra, P., Lubitz, S. A., Maddah, M., Vardeny, O., et al. (2025) · Circulation: Heart Failure

Artificial Intelligence in HealthcareHeart Failure Treatment and Management

Cited by 14

Artificial Intelligence-Enabled ECG Analysis to Predict Incident Heart Failure

Khurshid, S., Friedman, S. F., Kany, S., D’Souza, V., Roshandelpoor, A., Kosyakovsky, L. B., Chitsazan, M., Cunningham, J. W., Singh, P., Lau, E. S., et al. (2026) · Circulation: Heart Failure

ECG Monitoring and AnalysisArtificial Intelligence in Healthcare

Cited by 2